Navigation Links
Sigma(R) Launches Innovative ChIP Kit Technology For Epigenetic Research
Date:4/16/2008

print(TM) ChIP Kit is based on Chromatin Immunoprecipitation (ChIP) technology licensed from Epigentek Group.

"This arrangement reinforces Epigentek's leading position in the epigenetic arena," said Adam Li, Chief Scientific Officer for Epigentek. "We share Sigma's commitment to developing the next generation of research tools for epigenetic research."

About Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and High Technology company. Our biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high technology manufacturing. We have customers in life science companies, university and government institutions, hospitals, and in industry. Over one million scientists and technologists use our products. Sigma-Aldrich operates in 36 countries and has 7,900 employees providing excellent service worldwide. Sigma-Aldrich is committed to Accelerating Customer Success through Leadership in Life Science, High Technology and Service. For more information about Sigma-Aldrich, please visit our award-winning website at http://www.sigma-aldrich.com.

About Epigentek Group Inc: Epigentek Group Inc. is a biotechnology company that focuses on developing and providing innovative technology and products as a complete and systematic solution for epigenetics-related research and drug discovery. The company has developed a comprehensive portfolio of more than 400 proprietary products that are used all around the world by esteemed academia, leading pharmaceuticals, and cutting edge biotechnology companies. These unique products are specifically designed to make assays significantly more simple, fast, convenient and efficient than conventional methods. The company, particularly emphasizing speed and effectiveness in its technologies, continues to focus on e
'/>"/>

SOURCE Sigma-Aldrich
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. Cypress Systems, Inc. Launches Cancer Prevention Health Campaign Using SelenoExcell(R)
2. Cellix Ltd. Launches VenaEC Biochip for Flow-based Cell-adhesion Assays
3. Schering-Plough Launches Productivity Transformation Program To Confront New Challenges
4. IC Sciences Launches ICS Alliance to Advance Development and Adoption of Informatics Instruments for Next Generation Healthcare
5. Biotage Launches New 24 Well Pyrosequencing(R) System
6. Ferring Initial Purchase Order and Guaranteed Letter of Credit Launches Five Year Contract
7. Encision Launches Next Generation of EnTouch(R) Handles for Advanced Laparoscopic Procedures
8. Sagent Pharmaceuticals Launches Cefazolin for Injection, USP
9. BioElectronics Launches 1 Day Breast Augmentation Recovery Kit
10. Allen Institute for Brain Science Launches Three New Landmark Atlas Projects Focusing on the Human Brain, Developing Brain and Spinal Cord
11. Altogen Biosystems Launches Custom Biotechnology Research Services: Generation of Stable Cell Lines and RNAi Cell Transfection Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Dec. 15 Thomson ... ® has become the first drug pipeline database ... outcome information. This highly anticipated new content is ... month. ,, Thomson Pharma ... registries, publications, press releases, conferences, and other sources ...
(Date:12/15/2009)... Office has announced the launch of several innovative new ... services in the current economic climate. The first ... to finance legal services over a period of 6, ... in their start-up companies. The second is aimed ... payment arrangements over 6 to 12 month period at ...
(Date:12/14/2009)... Dec. 14 Vermillion, Inc. (Pink ... announced William C. Wallen, Ph.D. Chief Scientific ... for IDEXX Laboratories, will be joining its ... bankruptcy plan. ,, "Bill brings more ... in diagnostics and biotechnology," said Gail Page, ...
(Date:12/14/2009)... with State Biotech Leaders to Develop Blueprint ... Development while Boosting Rhode Island,s Growing Biotech ... R.I., Dec. 14 Several of ... medicine and biotechnology gathered today at Brown ... importance of medical innovation in Rhode Island ...
Breaking Biology Technology:Thomson Reuters is First to Offer Fully Integrated Pipeline and Clinical Trials 2The Prinz Law Office Launches Innovative New Programs to Aid Cash-Strapped Entrepreneurs and Businesses 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 3Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 4Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 2Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 3Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 4
... March 27 Diplomat Specialty,Pharmacy today announced Ken ... as National Accounts Manager of Multiple Sclerosis. Visser,works ... of Business,Development, and with Mark Neville, Vice President ... for the development and national launch of,Diplomat,s Multiple ...
... Financing Includes Equity Investment and Line of Credit ... Inc.,(OTC Bulletin Board: MODG), a biopharmaceutical company applying ... proteins, today announced that it has closed a ... investors and has entered into a,line of credit ...
... HOBOKEN, N.J. Through its GK-12 program, the ... (NSF) has awarded a grant of $3,000,000 to ... Technology, under the leadership of Professor Constantin Chassapis, ... to Chassapis, who serves as the Principal Investigator, ...
Other Biology Technology:Diplomat Specialty Pharmacy Hires National Accounts Manager to Expand Multiple Sclerosis Program 2Modigene Announces Closing of $12 Million Financing by Members of The Frost Group 2Modigene Announces Closing of $12 Million Financing by Members of The Frost Group 3Modigene Announces Closing of $12 Million Financing by Members of The Frost Group 4Modigene Announces Closing of $12 Million Financing by Members of The Frost Group 5Chassapis and team awarded $3 million GK-12 grant from NSF for multiscale research 2Chassapis and team awarded $3 million GK-12 grant from NSF for multiscale research 3
(Date:12/15/2009)... HERNDON, Va., Dec. 15 The PTR Group, ... today announced that it has agreed to sponsor three ... US FIRST Robotics Competition ( http://usfirst.org ). ... high school teams in three different states. The ... in Rockwall, TX, and James Madison HS in Vienna, ...
(Date:12/14/2009)... FAIRBANKS, AlaskaScientists have identified a novel antifreeze molecule in ... minus 100 degrees Fahrenheit. Unlike all previously described biological ... has little or no protein. It is composed of ... in new places within the cells of organisms. ... that this molecule is a whole new kind of ...
(Date:12/14/2009)... founded a new journal Cardiovascular Engineering and Technology ... a forum for research on all aspects of cardiovascular ... the new quarterly journal will appear in March 2010 ... Annals of Biomedical Engineering and Cellular and ... will present a wide spectrum of research, from ...
Breaking Biology News(10 mins):The PTR Group Announces Financial and Technical Support to US FIRST Robotics Competition Teams 2Scientists isolate new antifreeze molecule in Alaska beetle 2Biomedical Engineering Society's new journal to be published by Springer 2MDS Reports Third Quarter 2009 Financial Results 56733 1MDS Reports Third Quarter 2009 Financial Results 56733 2MDS Reports Third Quarter 2009 Financial Results 56733 3MDS Reports Third Quarter 2009 Financial Results 56733 4MDS Reports Third Quarter 2009 Financial Results 56733 5MDS Reports Third Quarter 2009 Financial Results 56733 6MDS Reports Third Quarter 2009 Financial Results 56733 7MDS Reports Third Quarter 2009 Financial Results 56733 8MDS Reports Third Quarter 2009 Financial Results 56733 9MDS Reports Third Quarter 2009 Financial Results 56733 10MDS Reports Third Quarter 2009 Financial Results 56733 11MDS Reports Third Quarter 2009 Financial Results 56733 12MDS Reports Third Quarter 2009 Financial Results 56733 13MDS Reports Third Quarter 2009 Financial Results 56733 14MDS Reports Third Quarter 2009 Financial Results 56733 15MDS Reports Third Quarter 2009 Financial Results 56733 16MDS Reports Third Quarter 2009 Financial Results 56733 17MDS Reports Third Quarter 2009 Financial Results 56733 18MDS Reports Third Quarter 2009 Financial Results 56733 19MDS Reports Third Quarter 2009 Financial Results 56733 20MDS Reports Third Quarter 2009 Financial Results 56733 21MDS Reports Third Quarter 2009 Financial Results 56733 22MDS Reports Third Quarter 2009 Financial Results 56733 23MAP Pharmaceuticals Analysis of Positive Phase 3 LEVADEX 28TM 29 Data To Be Presented in Late Breaking Session at 14th Congress of the International H 4961 1MAP Pharmaceuticals Analysis of Positive Phase 3 LEVADEX 28TM 29 Data To Be Presented in Late Breaking Session at 14th Congress of the International H 4961 2MAP Pharmaceuticals Analysis of Positive Phase 3 LEVADEX 28TM 29 Data To Be Presented in Late Breaking Session at 14th Congress of the International H 4961 3MAP Pharmaceuticals Analysis of Positive Phase 3 LEVADEX 28TM 29 Data To Be Presented in Late Breaking Session at 14th Congress of the International H 4961 4MAP Pharmaceuticals Analysis of Positive Phase 3 LEVADEX 28TM 29 Data To Be Presented in Late Breaking Session at 14th Congress of the International H 4961 5MAP Pharmaceuticals Analysis of Positive Phase 3 LEVADEX 28TM 29 Data To Be Presented in Late Breaking Session at 14th Congress of the International H 4961 6Stereotaxis Awarded Exclusive Contract by Novation for Robotic Interventional Technology 56729 1Stereotaxis Awarded Exclusive Contract by Novation for Robotic Interventional Technology 56729 2Stereotaxis Awarded Exclusive Contract by Novation for Robotic Interventional Technology 56729 3Stereotaxis Awarded Exclusive Contract by Novation for Robotic Interventional Technology 56729 4
... Consortium say they are absolutely delighted by todays ... host a new 1billion national institute to develop ... of the universities of Birmingham, Loughborough and Nottingham ... complementary energy related research activities. Generous financial ...
... Seattle will be the place to be on September 27 ... overseas gather to present their news. The second Future ... of Child Health and Human Development, CONRAD, the World Health ... Seattles Edgewater Hotel overlooking the Puget Sound. Registration is ...
... Ali Saib are joint winners of the 2007 EMBO ... present science in a unique format that is both ... award. Using different media, they have produced resources for ... to the broader community. , Professor Ali Saib of ...
Other Biology News:Midlands Consortium delighted to be chosen to host £1 billion energy institute 2Midlands Consortium delighted to be chosen to host £1 billion energy institute 32 French scientists win European award for communication 22 French scientists win European award for communication 3
... Ligands\n\nReceptor-related research has long been enabled by ... selected to keep pace with new discoveries. ... and services for receptor research and drug ... you do not find exactly what you ...
... TURBO DNase (patent pending) was developed using a ... into the DNA binding pocket of wild-type DNase ... the protein for DNA. The result is a ... for DNA, and an ability to maintain at ...
Rabbit polyclonal to hnRNP-U...
... DNA Ligase catalyzes the formation of a ... termini in nicked duplex DNA molecules or ... a complementary strand at 45 - 65?. ... at much higher temperatures than conventional DNA ...
Biology Products: